>>NARRATOR: A vast expanse of liquid hope,
the oceans are part of America's newest medical frontier.
Its underwater organisms are teeming with potential cures.
>>Sponges are providing real chemicals, real pharmaceuticals.
>>About 70% of the drugs that we use now have their origin
in some natural product.
Most of them are plant-derived.
So can you imagine how much more there is
when two-thirds of the world is covered by water?
The potential is unlimited.
>>NARRATOR: The latest medical gold rush
takes place beneath the waves.
Marine creatures may hold the key
to unlocking the secrets of our own biology.
>>The horseshoe crab and its eyes
are really quite remarkable.
They become about a million times more sensitive at night
than they are during the day.
>>We've used that information to be able to get a better sense
of how human eyes work.
>>Aplysia fits the niche for a basic animal
that can be used to study memory and learning.
>>The compound that comes from a shallow water sponge
can help to block the spread of cancer.
>>NARRATOR: Scientists view this saltwater wilderness
as a treasure chest of promise for human medicine.
>>I still feel like I'm a kid in a candy store,
because marine natural products are amazing.
They have such potential to really be new drugs,
and yet we have just scratched the surface.
>>NARRATOR: The ocean's medical mysteries
are as deep as its trenches.
What breakthroughs have its sea life revealed?
Are there cures that lie beneath the waves?
>>Major funding for this program was provided
by the Batchelor Foundation,
encouraging people to preserve and protect
America's underwater resources.
>>NARRATOR: For centuries, man has looked to the oceans
for organic remedies to alleviate human illness.
In 1987, a chemical isolated from a Caribbean sponge
was the first drug approved for treatment of the HIV infection.
Toxins from a venomous cone snail
offer relief to those suffering from severe chronic pain.
Once again, the seas are proving to be
a valuable resource for medical research.
>>Over the last ten to 20 years,
we've been doing more and more research in this environment,
looking at the marine environment,
looking at shallow waters, going into deep waters.
And with our work,
we're looking at things which are associated
with invertebrates.
>>NARRATOR: In Florida, a team of scientists
at Harbor Branch Oceanographic Institute
are testing sea sponges
for their potential anticancer properties.
>>Our main focus right now is pancreatic cancer,
because it is the fourth leading cause of death
of cancer in the U.S.,
and it is one of those that only has a 5% survival rate.
So that means only 5% of the patients make it past five years
of being diagnosed.
So the drugs that we have right now are not very effective,
and we desperately need new drugs for pancreatic cancer.
Normally, the way it goes, we go on the sub, you get a sponge,
the chemists make extracts and then we test different abilities
that these compounds might have to fight cancer.
>>NARRATOR: The Center for Marine Biomedical
and Biotechnology Research at Harbor Branch
houses invertebrate specimens that have been collected
throughout the world's oceans.
Explorers use state-of-the-art research vessels
and manned submersibles to gather sea-dwelling creatures.
>>So Harbor Branch has had the Johnson Sea Link submersibles,
and they dive to 3,000 feet of seawater-- or 910 meters--
and they are fully outfitted with a work platform
that allows us to collect different organisms.
>>NARRATOR: Once an organism has been collected,
chemists break down the specimen
and begin the process of purification.
After an extract has been isolated,
scientists like Dr. Esther Guzman
perform a series of tests to determine
if the item shows activity against cancer cells.
>>Sponges cannot do much other than being in their little site,
so that makes them nice little chemical factories,
because everything that they want to do,
whether it's grow or expand
or attract another sponge to reproduce,
they do this by releasing things into the water.
That little sponge, as innocent as it looks,
it's making some very heavy chemicals.
If you put, for example, a drop of perfume in a glass of water,
you're going to lose that smell.
So think about how potent the signals of a sponge are,
because they are releasing it in more than a glass of water;
they are releasing it to the sea.
>>NARRATOR: One of these "chemical factories"
is the Caribbean barrel sponge.
It contains a compound called manzamine A,
which has drawn a lot of attention from scientists.
>>We've shown recently it can help to block
the spread of the cancer.
>>If you think about pancreatic cancer,
the reason it's very aggressive
is that normally when it's detected,
it has already migrated to another organ,
so it has already metastasized.
Manzamine A stops that process.
One of the characteristics of cancer cells
is that they don't need this cell-to-cell interaction.
They actually thrive on their own,
and that might be one of the characteristics also
that can lead to this spreading to another organ.
And if you put manzamine A in their midst at low doses,
it kind of returns the cell-to-cell interaction.
It also prevents the cells from migrating
from one organ to another.
>>NARRATOR: In addition to manzamine A,
another sponge extract that shows promise
for cancer therapies is discodermolide.
Initially developed as an immunosuppressant,
discodermolide, which comes from a Bahamian sea sponge,
functions similarly to Taxol,
a pharmaceutical commonly used to treat patients with ovarian,
breast or lung cancer,
as well as patients with AIDS-related Kaposi's sarcoma.
>>Taxol is one of the major drugs used to treat cancer,
and it was isolated from a yew tree.
The way Taxol works is that it freezes
or hyper-stabilizes tubulin.
Tubulin is a protein that is in all your cells.
and it helps to give cells shape.
It is very necessary when the cells are going to divide.
When you put Taxol in a cell that is dividing,
the cell can no longer align itself,
and so these cells will die.
There are certain tumors that do not respond to it,
and there are certain tumors that become resistant to it.
Discodermolide is about the same potency as Taxol,
but it is still effective on cells
that have become resistant to Taxol.
>>NARRATOR: Researchers at Harbor Branch
are also looking for chemical agents that can target
malignant cells efficiently
without suppressing healthy body systems.
>>One of the major problems that we have
with cancer treatments or with chemotherapies
is that you tend to kill normal cells
as much as you're killing cancer cells.
>>NARRATOR: A sponge found in Bahamian waters
contains a compound that may help reduce
patient side effects through cell selectivity.
Leiodermatolide, its chemical extract,
shows greater activity against cancer cells
than healthy cells.
>>Having this selectivity-- that it kills
6,000 times more cancer cells than normal cells--
is that then you will have less side effects,
because in certain senses you are weakening the patient
while you are trying to kill the cancer.
>>NARRATOR: The marine natural products from Harbor Branch
are in various stages of testing.
Getting drugs approved
by the U.S. Food and Drug Administration
is a lengthy process,
one that can take years before the public can gain access
to novel compounds such as these.
However, cancer biologists like Dr. Guzman
are still optimistic that sponges will one day
provide better medicines to treat pancreatic cancer.
They are living fossils.
Horseshoe crabs are curiously resilient
and unassuming creatures whose unique biology
has captivated the interest of man for decades.
More closely related to spiders and scorpions
than to true crabs, ancestors of horseshoe crabs
existed 350 million years ago,
long before the age of dinosaurs.
In the 1900s,
horseshoe crabs were commonly used in the farming industry
as crop fertilizers and as feed for livestock.
By the mid-1970s,
commercial fishermen began using them as bait
for eel and conch fisheries.
But it's the crab's "blue blood"
that revolutionized the medical industry.
>>They have a special chemical in their blood
that's used to detect the presence of bacterium.
>>That bacterium assay is used to screen everything
that goes into a human being and to test
the sterility of all the machines that are used
to deliver such products, like IV fluids.
>>NARRATOR: And that's not the only factor
that makes horseshoe crabs of interest to modern science.
Dr. Barbara Battelle from the University of Florida's
Whitney Lab for Marine Bioscience in Marineland
focuses on the animal's distinct visual system.
>>Well, it has ten eyes--
two compound eyes that are just like fly eyes.
These are the big eyes that you see on the sides of the carapace
or the upper part of the animal.
And the photoreceptors are very large,
among the largest in nature, so in experimental preparation,
they're really very useful.
>>NARRATOR: Horseshoe crabs have roughly
1,000 photoreceptors, or light-sensitive cells,
in each compound eye,
compared to the millions found in human eyes.
>>There are many people that have reduced vision,
and we don't have an explanation for it.
Why is vision going down?
How does that happen?
Well, in mammals it's difficult to study,
because our eyes are complex.
>>NARRATOR: In 1976,
researchers from Syracuse University discovered
that manipulation of an optic nerve that transmits signals
from the brain to the compound eyes of a horseshoe crab
mimics the visual function of circadian clocks.
>>Circadian clocks are internal clocks
that we have in our cells and in our brain
that make us change our physiology, day to night.
And we experience the effects of our circadian clocks
when we travel across time zones.
The circadian clock in your brain
doesn't only control your sleep-wake cycle;
it also controls how our eyes work.
>>NARRATOR: In 1967, Dr. Haldan Keffer Hartline
and his colleagues at the Marine Biological Laboratory
in Woods Hole, Massachusetts,
won the Nobel Prize for their work examining horseshoe crabs.
They identified lateral inhibition,
a visual process in animals and humans alike
that enhances contrast,
helping the eye to see borders and edges.
Scientists at the Whitney Lab
hope this species will provide even more clues
on the basic mechanisms of vision.
>>Oftentimes, our circadian rhythms degrade as we age,
and it could be that some of the reasons
for impaired vision as we get older
is that the signals from the circadian clock are degrading,
and the cells aren't getting the information they should get.
>>NARRATOR: To test this theory,
Dr. Battelle works with live specimens from her wet lab,
where a skylight provides
natural day- and night-time light patterns.
Tissue samples from the compound eye
are analyzed to detect any biochemical changes
that occur in response to internal or external stimuli.
>>We discovered a major protein in the photoreceptors.
So a protein is the part of the cell
that actually does the work of the cell.
So we found a major protein
that is changed in response to the signal
from the central 24-hour clock.
And we don't really know what that protein does yet,
but we think it has a major impact
on the way the photoreceptor cells function.
>>NARRATOR: By controlling circadian input
to the compound eye,
lab tests revealed concentrations
of the newly discovered protein, opsin 5.
Although similar proteins are far more abundant
during the night and day,
opsin 5 molecules may still impact photoresponse.
>>So we can see these proteins actually move around.
They're in different places depending on the time of day,
and that gives us some clue
about how the photoreceptor is changing its sensitivity,
day to night-- clock input, no clock input, and so forth.
So it gives us a clue of what's going on inside the cell.
>>NARRATOR: Studies indicate that light,
as well as the animal's circadian clock,
regulate opsin 5 differently
than other photosensitive proteins.
Experts suspect that changes in levels may underlie
some the dramatic day-night changes in photoreceptors.
>>The horseshoe crab and its eyes
become about a million times more sensitive at night
than they are during the day, and what's really interesting
is that we found the same kind of protein
in the photoreceptors of mammals.
And that's the way
the sort of comparative biology that we do works.
We find something in a simpler organism, and then we ask,
"Well, are we finding the same sorts of things
in other organisms?"
Basic mechanisms that go on in cells, regardless of species,
are similar.
And as we discover what this protein does
in the horseshoe crab eye, then we can begin to ask
more pointed questions about what it might be doing
in our own eyes.
So, if we can figure out how to make
cells more sensitive to light,
then the potential is that we can fix them.
>>NARRATOR: Marine invertebrates
are seemingly basic organisms.
Yet their simplistic anatomies offer great insights
into the way the human nervous system functions.
The larvae of starfish help researchers understand
how the body defends itself against disease.
The mechanisms by which nerve impulses travel
along nerve fibers was discovered via studies on squid.
In 2000, experiments with sea slugs won Eric Kandel
and his colleagues at Columbia University
the Nobel Prize in medicine
for their work on the cellular processes
of learning and memory.
The National Resource for Aplysia in Miami
is the only facility in the world
where sea slugs are raised for research purposes.
>> Aplysia californica has become an important model
for studying the development of the nervous system,
learning, behavior.
>>NARRATOR: In 1975, Thomas Capo joined Eric Kandel
at Columbia University, where he worked to improve
the availability of sea slugs, or aplysia,
for year-round studies.
>>Aplysia are an annual animal.
If you want to work with small animals in the late summer,
you can't find them.
Or, if you wanted to work with small animals in the winter,
they're not available.
So what we do here
at the University of Miami's Aplysia Resources,
we raise animals throughout the year.
>>NARRATOR: Before coming to Miami,
researchers moved to Woods Hole, Massachusetts,
where original aquacultural operations began
on Aplysia californica, a species commonly found
on the West Coast of the United States.
>>By 1978, we had moved to Woods Hole,
and it's there that we made the major breakthroughs
in getting large numbers of animals through the larval phase
and the metamorphic phases.
And once we were able to grow large numbers of animals,
it became obvious that we needed a larger facility,
a better facility, and there was a major problem
working in Woods Hole, and that was food supply.
And in Florida, at the University of Miami's
experimental facility on Virginia Beach
was the ideal place,
because not only did we have an abundant supply
of ambient seawater,
we also had warm weather to culture the algae.
And within two or three years of moving here in 1989,
we were able to culture over 300,
400 pounds of seaweed a week,
which was necessary to produce the animals.
And also, we had an abundant supply of raw seawater
which we could clean up, chill down
and grow our animals in.
The facility was initially set up
to produce around 10,000 animals,
but we've expanded several times over the years,
and now we produce anywhere
between 25,000 and 30,000 animals a year
for researchers around the world.
>>NARRATOR: One of those researchers, Dr. Leonid Moroz,
works at the University of Florida's Whitney Lab.
His studies focus on how individual nerve cells
function in relation to memory and learning.
>>Aplysia offers this opportunity,
because it has a relatively simple neurosystem,
with only about 100 cells per ganglion
and roughly 10,000 cells in the whole brain--
and, importantly, most of these neurons are giant.
You can study connections of the cells
and, most importantly, you can link everything to behavior.
>>NARRATOR: Aplysia neurons are so large,
they can be seen by the naked eye.
They possess nine groups of nerve cells, or ganglia,
within their bodies, distinct physical features
that help experimental scientists view aplysia
as a model organisms for neuroscience research.
>>Aplysia seem to be an interesting approach,
a reductionist approach whereby you look at an animal
with a small number of neurons
and basically get an understanding
of how the nervous system works.
>>If you remember your first kiss,
more likely what would happen in your brain--
or happened in your brain-- is that cell A and cell B
and cell C, they just talk to each other,
and synapses, the connections between cells, become stronger
and, more likely, they change shape.
So efficiency of these connections becomes better
or less better.
So if it's better, you will more likely remember something;
if it's weaker, you will lose this memory.
>>NARRATOR: Dr. Moroz examines how aplysia neurons
and synapses change as a result of memory formations.
Similar to Pavlov's famous salivating dogs experiment,
Dr. Moroz can elicit specific behaviors from sea slugs
through basic forms of learning.
>>You give to aplysia a simple task.
You produce tactical stimulation which is associated
with some kind of algae or juice.
In aplysia, you'll produce a feeding reaction
following this weak stimulus, which normally
they do not produce.
So you do, like, 40 repetitions, and aplysia will remember.
So this is a sort of elementary learning and memory.
It's called associative type of memory, when animals associate
to a type of stimulus, make connections,
and basically preserve those connections for quite a while.
So you count the number of synapses between cells
before and after memory formations.
So in older aplysia, this number of connections
becomes weaker,
and a similar process happens in the human brain
or a variety of neurological diseases.
So everything you learn and remember,
it's really linked to how one neuron talks to each other
and how they preserve this efficiency
of these communications.
So you can reduce complex memory process
to the level of only a few cells.
In fact, many people would be surprised
how many neurons would need to form
elementary forms of memory; only three cells is sufficient.
>>NARRATOR: By studying learning and memory
at the cellular level, Dr. Moroz hopes his experiments
will one day lead to solutions for neurodegenerative conditions
such as Alzheimer's and Parkinson's diseases.
>>I bet if you will solve the problem--
how in aplysia two neurons talk to each other,
how they modify the synapses-- it will be one or another way
to apply it to clinical studies or disease analysis.
>>NARRATOR: Scientists say it is important to study
a diverse group of species
to better understand complicated processes.
>>If everybody looked just at a rat or a mouse,
we'd know a lot about a rat or a mouse,
but we wouldn't have the full spectrum
of understanding about biology.
But by studying these simpler or less complex organisms,
we can learn a lot about basic processes,
and I think that remains critical to our understanding
of our own biology.
>>We know more about maybe rocks on the moon
than what lives in the ocean.
>>NARRATOR: Today's biomedical researchers
are diving into the deep blue,
hopeful the ocean's rich diversity of marine life
will reveal answers to man's greatest health issues.
>>One thing that's been very clear to us as marine scientists
over the last several decades
is that there are byproducts that we can extract
or get from many of these marine organisms
that can really benefit humans.
>>It holds so much wealth for us.
And we get our health from it.
We firmly believe there is a cure
down at the bottom of the sea.
>>Major funding for this program was provided
by the Batchelor Foundation,
encouraging people to preserve and protect
America's underwater resources.